News

Vir is holding off on advancing the combination therapy to Phase III trials until it secures a development partner.
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...
Vir Bio (VIR) reveals 24-week post-end-of-treatment data from a mid-stage trial for its Hep B therapy developed with Xencor ...
Nursing, M.Sc. and M. Biotechnology Programs at AIIMS New Delhi and other centres of AIIMS. (a) M.Sc. Nursing Specializations available: (i) Cardiological / CTVS Nursing (ii) Oncological Nursing ...
In RIT’s biotechnology bachelor’s degree you’ll develop technologies for genetics, agriculture, pharmaceuticals, vaccine development, energy/ environment, forensics, and more. Hands on Experience: ...
No­ma Ther­a­py, a vir­tu­al ke­t­a­mine-as­sist­ed ther­a­py provider, has launched with $4.25 mil­lion in fund­ing, End­points News learned ex­clu­sive­ly.
The Biotech Beach Hotbed includes San Diego, Los Angeles and the surrounding (Torrey Pines, Thousand Oaks) regions of Southern California. SoCal is well-known for its sprawling beaches and ...